Program Development

Developing Novel Treatments Through Microbiome Testing

Creating Microbial-Based Products To Treat Mental Illness

Taylored Biotherapeutics is a platform company researching and developing novel treatments for a variety of mental illnesses. Our research has found a significant association between the health of the brain and the gut microbiome, allowing us to tailor treatments for different illnesses.

Taylored Biotherapeutics is a neuroscience led company informed by some of the only clinical fecal transplant studies for mental illness in the world. This has supported a precision medicine approach to developing microbial therapeutics.

Current Pipeline

Product Name Safety and Efficacy Testing Bacterial Tracing Characterization Prototype Development Phase I
TBIBipDep-01 Completed Completed Completed Protocol Development
TBIDepression-02 Ongoing.
Anticipated end date: Q3 2023
Planned Planned Protocol Development
TBIOCD-03 Ongoing.
Anticipated end date: Q2 2023
Planned Planned Protocol Development
Data has been accrued in our developmental biobank for ADHD, Dementia, and Psychosis

See Our Lab

Researchers at Taylor Lab are discovering how the human microbiome impacts mental health.